Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507024 · ClinicalTrials.gov registry record
The ANCA Vasculitis Questionnaire (AAV-PRO©)
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 280
- Enrollment target
NCT02507024: Completed study, sponsored by University of Pennsylvania.
NCT02507024 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 280 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02507024 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflammation in the small blood vessels leading to involvement of a range of organs and can suffer from ongoing disease activity or treatment side effects. Quality of life can be measured by patient reported outcome measures (PROMs).
Primary Outcome
Analysis of how people fill in the questionnaire to determine if these specific questions work, and whether we need to ask all of them.
Interventions
- OTHER Online questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12 |
What the finished NCT02507024 record still lists
NCT02507024 is an observational study that tracks outcomes without assigning an intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Online questionnaire is the first listed.
NCT02507024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02507024 about?
NCT02507024 is a clinical study titled "The ANCA Vasculitis Questionnaire (AAV-PRO©)". The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflam...
What is the current status of trial NCT02507024?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2015-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02507024?
The interventions under investigation include: Online questionnaire (OTHER).
Who is sponsoring clinical trial NCT02507024?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia